{"id":"W3043725666","doi":"10.1136/esmoopen-2020-000672","title":"Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study","year":2020,"lang":"en","type":"article","venue":"ESMO Open","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharma; Novartis Pharmaceuticals Corporation","keywords":"Carboplatin; Medicine; Open label; Lomustine; Internal medicine; Oncology; Glioblastoma; Phases of clinical research; Randomized controlled trial; Clinical trial; Chemotherapy; Cisplatin; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003510666,0.002309352,0.003624032,0.0006720883,0.0004049504,0.001127685,0.00118114,0.001566646,0.003738301],"category_scores_gemma":[0.001753779,0.0009040388,0.002633207,0.0007426405,0.00141051,0.001400336,0.0006152751,0.002560674,0.0008739409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001832947,"about_ca_system_score_gemma":0.001939982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001570178,"about_ca_topic_score_gemma":0.003830376,"domain_scores_codex":[0.9981508,0.001077048,0.0001532298,0.0002362263,0.0001482338,0.0002344427],"domain_scores_gemma":[0.9987769,0.000182706,0.0003599756,0.00008989165,0.00008764317,0.0005029261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9435493,0.01618845,0.002647464,0.0009006835,0.001942125,0.0001092884,0.0001035992,0.0005079071,0.005449767,0.00007478951,0.001234759,0.02729186],"study_design_scores_gemma":[0.7803555,0.2127833,0.004491189,0.00003059843,0.0008174953,0.00009219655,0.00003220132,0.0002969349,0.0003670982,0.00007950993,0.0006308238,0.00002325015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872167,0.005653092,0.0004084312,0.0005938007,0.0002921658,0.004043808,0.0007366952,0.000090585,0.0009648181],"genre_scores_gemma":[0.9883727,0.003484054,0.0009439193,0.001208638,0.0004762329,0.003341063,0.001025365,0.00002113103,0.001126901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003738301,"threshold_uncertainty_score":0.01856643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05163462450066753,"score_gpt":0.3471709034432321,"score_spread":0.2955362789425646,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}